A Complicated Case of Transient Constrictive Pericarditis Secondary to Rivaroxaban-Associated Hemopericardium

JACC Case Rep. 2020 Sep 9;2(12):1947-1950. doi: 10.1016/j.jaccas.2020.07.021. eCollection 2020 Oct.


A 72-year-old man on rivaroxaban developed effusive constrictive pericarditis secondary to hemopericardium. His condition improved with anti-inflammatory therapy supporting a diagnosis of transient constrictive pericarditis. On follow-up, residual constriction developed requiring surgical pericardiectomy. Although many cases with transient constrictive pericarditis resolve with medical management, some may progress and require pericardiectomy. (Level of Difficulty: Advanced.).

Keywords: CP, constrictive pericarditis; DHE, delayed hyper-enhancement; ECP, effusive constrictive pericarditis; MRI, magnetic resonance imaging; NYHA, New York Heart Association; PWD, pulsed-wave Doppler; TCP, transient constrictive pericarditis; cardiac magnetic resonance imaging; effusive constrictive pericarditis; hemopericardium; pericarditis; recurrence; transient constrictive pericarditis.

Publication types

  • Case Reports